Individual provider · Type 1 NPI
Ananya Venkata Kondapalli Jhaveri
Endocrinology, Diabetes & Metabolism Physician · Dallas, TX
Practice location
2001 Inwood Road, 8th And 9th Fl
Dallas, TX 75390-8872
Mailing address
PO Box 845347
Dallas, TX 75284-5347
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Endocrinology, Diabetes & Metabolism Physician Primary | 207RE0101X | 25MA12792900 (NJ) |
| Hospitalist Physician | 208M00000X | 297851 (NY) |
| Endocrinology, Diabetes & Metabolism Physician | 207RE0101X | U2538 (TX) |
Endocrinology, Diabetes & Metabolism Physician: An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.
3 other providers at this address
Other endocrinology, diabetes & metabolism physician providers in Dallas
- Sasan Mirfakhraee, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1013063627
- Stanley Feld, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1023266459
- Peter Gerhard Christop Zechner, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1033349642
- Jaime Abraham Davidson, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1053345447
- Zahid S. Ahmad, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1053529099
- Sumitha Sukumar Hathiramani, MDEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1063622918
- Li SongEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1093072548
- Shamita Trivedi, DOEndocrinology, Diabetes & Metabolism Physician Dallas, TX NPI 1114187903
About NPI 1194187831
Ananya Venkata Kondapalli Jhaveri's National Provider Identifier is 1194187831, issued on Mar 22, 2016. The primary taxonomy on file is Endocrinology, Diabetes & Metabolism Physician (207RE0101X), and the practice location is in Dallas, TX. The record was last updated on Nov 4, 2025.